In this episode, we visit with Christopher Furmon who leads Vitro based in Colorado. Christopher doesn't come from a traditional biopharma track. Instead, he spent decades helping build the financial juggernaut Janus.
Vitro Biopharma has a goal to become a leader in developing differentiated product candidates in a rapid and efficient manner for the immunology and inflammatory market; and ultimately, to address well-established multi-billion-dollar commercial markets.
The team has over 30 years of drug discovery and development experience that has enabled them to identify and advance multiple product candidates from preclinical studies into clinical trials. Specifically, their extensive knowledge of immunology and inflammatory conditions informs their decision making to advance the scientific and clinical path to demonstrate proof-of-concept, with the goal of achieving an efficient timeframe and cost-effective budget. Visit them at www.vitrobiopharma.com
ScriptChain is a digital health platform that sits on top of EHR systems and requests patient medical data from the EHR, runs through the...
Dr. Gupta is very active working with innovative startups across medical device and digital health and serves as a Sr. Clinical Advisor with AngelMD...
Jaffar Raza, MD is a board certified Interventional Cardiologist affiliated with Lenox Hill, Hackensack and Holy name hospitals. He completed his residency in Internal...
